Cipher Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
23.00
4.00
17.00
14.00
13.00
8.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7.00
12.00
-4.00
-3.00
5.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
41.00
26.00
21.00
13.00
17.00
15.00
Cash Flow from Investing Activities
0.00
-109.00
0.00
0.00
0.00
-1.00
Cash Flow from Financing Activities
-56.00
53.00
-7.00
-2.00
-3.00
-10.00
Net Cash Inflow / Outflow
-14.00
-30.00
14.00
10.00
14.00
3.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-1.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CAD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cipher Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(CAD)
Change(%)
Profit Before Tax
23.9816636564212
-84.6896551002955
107.00
128.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
7.3036273339226
43.7099942676204
-36.00
-83.29%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
41.5357999097347
-32.0283318492666
73.00
229.68%
Cash Flow from Investing Activities
-0.0992074881784015
42.4345600338351
-42.00
-100.23%
Cash Flow from Financing Activities
-56.5510628388207
-12.3337641318682
-44.00
-358.51%
Net Cash Inflow / Outflow
-14.453552925597
-1.92753594729963
-13.00
-649.85%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.660917491667379
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 55.12% vs 24.01% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
41.54
26.78
55.12%






